Company Profiles

driven by the PitchBook Platform

Avizorex Pharma

Avizorex Pharma
2013 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$3.17M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of drugs for ophthalmic treatment. The company engages in research and development of therapeutic drugs for the treatment of dry eye syndrome.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
c/Baldiri Reixac 4-8
08028 Barcelona
Spain

+34 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avizorex Pharma’s full profile, request a free trial.

Avizorex Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 27-Oct-2014 $3.17M 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Avizorex Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
European Union Agency for Network and Information Security Government Minority 000 0000 000000 0
Inveready Technology Investment Group Venture Capital Minority 000 0000 000000 0

Avizorex Pharma Executive Team (3)

Name Title Board
Seat
Contact
Info
Patrick Tresserras Co-Founder, President, Chief Executive Officer & Board Member
Jordi Petit Salamo Chief Financial Officer
Carlos Belmonte Ph.D Co-Founder

Avizorex Pharma Board Members (3)

Name Representing Role Since Contact
Info
Patrick Tresserras Avizorex Pharma Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Roger Piqué Pijuan Inveready Technology Investment Group Board Member 000 0000
Sara Secall Inveready Technology Investment Group Board Member 000 0000
Questions or concerns about this profile? Reach out to website-support@pitchbook.com